Previous 10 | Next 10 |
Summary IQVIA Holdings Inc. bottomed on June 16 and has since rallied 28% in a breakout attempt that finally failed. IQVIA Holdings stock is a strong leader in its industry, and despite some recent weakness, has significantly outperformed the broader healthcare sector. With 11...
Summary A high level of restructuring is occurring with the Healthcare industry’s largest constituents. Most restructuring is taking the form of splits or spin-offs, but not all incidences look beneficial. This article will summarize coming transactions and provide comm...
The study found faster, less expensive, and more engaging trials can be achieved using tech-enabled decentralized clinical trial models IQVIA ™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the ...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Baird 2022 Global Healthcare Conference in New York City on Wednesday, September 14, 2022 at 2:35 p.m. ET. A live audio webcast of the pr...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Morgan Stanley Annual Global Healthcare Conference in New York City on Tuesday, September 13, 2022 at 11:10 a.m. ET. A ...
Dan Loeb's 13F portfolio value decreased from $7.68B to $4.22B this quarter. The number of positions decreased from 75 to 58. Third Point added Colgate-Palmolive, Antero Resources, Walt Disney, and T-Mobile US. They also increased Ovintiv. However, net equity exposure was cut sharply ...
Lazard Global Total Return & Income Fund is a closed-end fund that has been operating since 2004. The vehicle has an interesting structure with an Equity / Debt and FX allocation. The vehicle has good long term analytics with a 0.49 Sharpe ratio and a 5-year lookback annualize...
IQVIA Holdings is above key moving averages. IQVIA Holdings is outperforming the S&P 500 index. Price action is analyzed to determine an initial stop loss for IQVIA Holdings. This article will look at the life sciences technology company IQVIA Holdings Inc. ( IQV ...
IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced it has been named the 2022 Marketplace Healthcare and Life Sciences Partner of the Year by Snowflake, the Data Cloud c...
GSK ( NYSE: GSK ) Iqvia ( NYSE: IQV ) launched Vaccine Track, a platform to track vaccination data across the U.S. The companies said the platform will be for use by public health officials, industry leaders and medical professionals to strengthen vaccinat...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...